Vomiting News and Research

RSS

Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.

Study sheds new light on potential habit-forming properties of tramadol

A study by a team of University of Kentucky researchers has shed new light on the potential habit-forming properties of the popular pain medication tramadol, in research funded by the National Institute on Drug Abuse.

27 Sep 2012

Dexamethasone use during tonsillectomy not associated with excessive bleeding in children

Tonsillectomy is exceedingly common, with a reported increase in tonsillectomy rates in children younger than 15 years from 287,000 to 530,000 per year over the past decade. Although safe, adenotonsillectomy can result in significant complications, such as aspiration and bleeding. Complications are infrequent, but because tonsillectomy is so common, the absolute number of children experiencing tonsillectomy complications is formidable.

26 Sep 2012

Extended release exenatide outperforms twice daily regimen

Once-weekly extended-release exenatide is a more effective treatment than twice-daily exenatide at improving glucose control among Japanese individuals with diabetes, report researchers.

24 Sep 2012

FDA approves Mylan's ANDA for generic Antivert

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Meclizine Hydrochloride Tablets USP, 12.5 mg, 25 mg and 50 mg.

21 Sep 2012

FDA approves Acton’s AEROSPAN sNDA to treat asthma

Acton Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the sNDA (Supplemental New Drug Application) for AEROSPAN (flunisolide HFA, 80 mcg) Inhalation Aerosol, a hydrofluoroalkane (HFA) orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients 6 years of age and older.

21 Sep 2012

St. Jude Medical’s Eon family of neurostimulators receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced it has received European CE Mark approval of its Eon family of neurostimulators for patients with intractable chronic migraine. Unveiled at the European Headache and Migraine Trust International Congress in London, this approval includes the Eon Mini neurostimulator, which is the world's smallest rechargeable neurostimulator with the longest-lasting battery in its class, and the Eon and EonC neurostimulators.

21 Sep 2012

Boehringer Ingelheim files MAA with EMA for afatinib approval

Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib, the first irreversible ErbB Family Blocker, as a treatment for patients with EGFR (ErbB1) mutation positive non-small cell lung cancer (NSCLC). Afatinib has demonstrated unprecedented efficacy versus chemotherapy in the Phase III LUX-Lung 3 registration trial, which provides pivotal support for this submission.

20 Sep 2012

Warning signs of eating disorders in children

It's a discussion that strikes fear in the hearts of most parents – adolescents expressing concern about their weight. According to statistics, 1 out of every 100 girls, between the ages of 10 and 20, struggles with anorexia and four percent of college-aged women have bulimia. So how can parents distinguish between normal adolescent insecurities and the start of a dangerous eating disorder?

19 Sep 2012

Inhaled pain relief effective in first labor stage

A Cochrane review shows that inhaled pain relief is more effective than no pain relief at all in reducing pain intensity during the first stage of labor, say researchers.

19 Sep 2012

HER Foundation donates $46000 to UCLA geneticist for research into Hyperemesis Gravidarum

The HER Foundation proudly presented a check for more than $46 thousand to Dr. Marlena Fejzo, geneticist, of the David Geffen School of Medicine at UCLA on Friday, September 14th.

18 Sep 2012

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Pfizer Oncology today announced that important data from its lung cancer and renal cell carcinoma (RCC) portfolios will be presented at the upcoming European Society for Medical Oncology (ESMO) Congress in Vienna, Austria, September 28 - October 2, 2012.

18 Sep 2012

Drinking water fails to meet state quality standards at North Carolina migrant farmworker camps

The drinking water at one-third of migrant farmworker camps in eastern North Carolina failed to meet state quality standards, according to a new study from Wake Forest Baptist Medical Center.

15 Sep 2012

Objective response rate promising after crizotinib for NSCLC

More than half of the latest evaluated participants from the ongoing phase II PROFILE 1005 trial of crizotinib against ALK-positive advanced non-small-cell lung cancer, achieved an objective tumor response, report researchers.

14 Sep 2012

Incidence of Acute gastrointestinal illness is likely to rise in coming years

The distribution system piping in U.S. public water systems that rely on non-disinfected well water or "ground water" may be a largely unrecognized cause of up to 1.1 million annual cases of acute gastrointestinal illness (AGI), involving nausea, vomiting and diarrhea, scientists are reporting. Their study in ACS' journal Environmental Science & Technology concludes that such illnesses may become more of a problem as much of the nation's drinking water supply system continues to age and deteriorate.

13 Sep 2012

Transcept completes enrollment in TO-2061 Phase 2 trial for obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to first-line treatment with an approved OCD medication.

12 Sep 2012

Inhaled analgesia appears to be effective in reducing pain intensity in first stage of labour

Inhaled pain relief appears to be effective in reducing pain intensity and in giving pain relief in the first stage of labour, say Cochrane researchers.

12 Sep 2012

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Santarus, Inc. today announced that its Phase III clinical study to evaluate the safety and efficacy of the investigational drug, rifamycin SV MMX, met the primary endpoint of reducing time to last unformed stool (TLUS) in patients with travelers' diarrhea.

12 Sep 2012

Concussion: an interview with Dr Rob Reid

Concussion happens when something produces a concussive force to the head, such as a blow to the head. The definition from the 2008 consensus, which was in Zurich, is, “concussion is defined as a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces.”

10 Sep 2012

All kids are susceptible to concussions

The gridiron is back in action. From little leagues to professional teams, football frenzy has begun, and with it, concerns about concussions. But it's not just jarring tackles that can lead to concussions in kids. According to Dr. Ryan Coates, pediatric neurologist at Loyola University Health System, there are many ways kids are exposed to concussion risks.

6 Sep 2012

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.

6 Sep 2012

Vomiting News and Research

Further Reading

Study sheds new light on potential habit-forming properties of tramadol

Dexamethasone use during tonsillectomy not associated with excessive bleeding in children

Extended release exenatide outperforms twice daily regimen

FDA approves Mylan's ANDA for generic Antivert

FDA approves Acton’s AEROSPAN sNDA to treat asthma

St. Jude Medical’s Eon family of neurostimulators receives European CE Mark approval

Boehringer Ingelheim files MAA with EMA for afatinib approval

Warning signs of eating disorders in children

Inhaled pain relief effective in first labor stage

HER Foundation donates $46000 to UCLA geneticist for research into Hyperemesis Gravidarum

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Drinking water fails to meet state quality standards at North Carolina migrant farmworker camps

Objective response rate promising after crizotinib for NSCLC

Incidence of Acute gastrointestinal illness is likely to rise in coming years

Transcept completes enrollment in TO-2061 Phase 2 trial for obsessive compulsive disorder

Inhaled analgesia appears to be effective in reducing pain intensity in first stage of labour

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Concussion: an interview with Dr Rob Reid

All kids are susceptible to concussions

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News